Nefecon and Ambrisentan in IgA Nephropathy
Clinical trial NCT07030894 · RECRUITING
Trial details
- NCT number
- NCT07030894
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-12-31
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.